Detalles de la búsqueda
1.
Assessment of effect of CYP3A inhibition, CYP induction, OATP1B inhibition, and high-fat meal on pharmacokinetics of the JAK1 inhibitor upadacitinib.
Br J Clin Pharmacol
; 83(10): 2242-2248, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28503781
2.
A Phase IIb Study of ABT-494, a Selective JAK-1 Inhibitor, in Patients With Rheumatoid Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Therapy.
Arthritis Rheumatol
; 68(12): 2867-2877, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27389975
3.
Efficacy and Safety of ABT-494, a Selective JAK-1 Inhibitor, in a Phase IIb Study in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate.
Arthritis Rheumatol
; 68(12): 2857-2866, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27390150
Resultados
1 -
3
de 3
1
Próxima >
>>